CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Transcriptional regulator SATB1 limits CD8(+) T cell population expansion and effector differentiation in chronic infection and cancer.
Transcriptional regulator SATB1 limits CD8(+) T cell population expansion and effector differentiation in chronic infection and cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
CD8+ T细胞是抗病毒和抗肿瘤免疫的主要介质。然而,在慢性感染和癌症等持续性抗原刺激过程中,它们会分化为功能受损的耗竭T细胞。耗竭T细胞前体(TPEX)细胞具有干细胞样特性,包括高增殖、自我更新和发育潜能,并负责针对持续性抗原的长期CD8+ T细胞应答。在此,我们确定染色质组织因子和转录调控因子SATB1是耗竭CD8+ T细胞分化的重要调控因子。SATB1特异性表达于TPEX细胞中,在那里它限制群体扩增和效应分化,同时保留CD8+ T细胞的功能。SATB1下调是慢性感染中TPEX细胞向效应细胞分化所必需的,并有助于急性病毒感染中效应和记忆分化的协调。SATB1的DNA结合以依赖和不依赖染色质可及性的方式调控基因表达。最后,SATB1限制抗肿瘤CD8+和CAR-T 细胞免疫。总体而言,我们的结果确定SATB1是感染和癌症中CD8+ T细胞前体命运和效应分化的核心调控因子。
CD8 + T cells are major mediators of antiviral and antitumor immunity. During persistent antigen stimulation as in chronic infection and cancer, however, they differentiate into exhausted T cells that display impaired functionality. Precursors of exhausted T (T PEX ) cells exhibit stem-like properties, including high proliferative, self-renewal and developmental potential, and are responsible for long-term CD8 + T cell responses against persistent antigens.
Here we identify the chromatin organizer and transcriptional regulator SATB1 as a major regulator of exhausted CD8 + T cell differentiation. SATB1 was specifically expressed in T PEX cells where it limited population expansion and effector differentiation while preserving functionality of CD8 + T cells.
SATB1 downregulation was required for T PEX cell-to-effector cell differentiation in chronic infection and contributed to coordinated effector and memory differentiation in acute viral infection. DNA binding of SATB1 regulated gene expression both dependent and independent of chromatin accessibility.
Finally, SATB1 limited antitumor CD8 + and chimeric antigen receptor T cell immunity.
Overall, our results identify SATB1 as a central regulator of precursor fate and effector differentiation of CD8 + T cells both in infection and in cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。